SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?


To: mokelumne river who wrote (1287)6/5/2015 12:54:24 PM
From: eico20  Respond to of 2026
 
I totally agree with you James



To: mokelumne river who wrote (1287)6/5/2015 7:12:46 PM
From: phoenix_rising  Respond to of 2026
 
Ok, when you put it that way MR... :)



To: mokelumne river who wrote (1287)6/6/2015 2:53:21 AM
From: phoenix_rising  Read Replies (1) | Respond to of 2026
 
I don't believe any big pharma will partner for Europe unless they get a slice of USA also considering Apri will use a European approval towards USA approval. In a utopian world, they would partner with Actavis snd work out a deal to combine Vitaros and Femprox (in my wee utopian dream world anyway).